PCRX
Pacira BioSciences, Inc.
27.04
USD
This page is just a preview of the data found in TrendSpider’s full version
Pacira BioSciences, Inc. stock is down -4.32% since 30 days ago. The next earnings date is Feb 27, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 69.23% of the previous 12 November’s closed higher than October. In the last 2 Unusual Options Trades, there were 2 CALLs. 100% of analysts rate it a buy.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 03 Oct 15:27 | 20 Oct, 2023 | 30.00 | 0 | ||
| 16 Oct 18:57 | 21 Jun, 2024 | 25.00 | 0 |
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectionable suspension. iovera system produces controlled doses of cold temperature only to targeted nerves.
